Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Investments Regulatory News (BRH)

  • There is currently no data for BRH

Replacement: Exercise of Options & Block Admission

5 Mar 2021 07:00

RNS Number : 2550R
Braveheart Investment Group plc
05 March 2021
 

5 March 2021

Correction: the following announcement replaces the notification released on 03 March 2021 at 4.29 p.m. under RNS number 0830R.

 

The original RNS incorrectly stated Trevor Brown's resulting percentage of enlarged issued share as 25.55 and resulting interest in Ordinary Shares capital as 9,788,288. The correct numbers are 23.09 and 8,843,288, respectively.

 

Braveheart Investment Group plc

("Braveheart" or the "Company")

Exercise of Employee Share Options, Block Admission Application, Issue of Equity and

Total Voting Rights

 

Braveheart Investment Group (AIM: BRH) announces that it has received notices of exercise of employee share options by Trevor Brown, a director of the Company, over a total of 1,200,000 new ordinary shares of 2p each (the "New Shares") as follows:

 

Following the issue of these shares Trevor Brown will have the following interest in the Company's Ordinary Shares:

Name of Director

Role

Number of New Shares

Resulting interest in Ordinary Shares

Resulting percentage of enlarged issued share capital

Trevor Brown

CEO

1,200,000

8,843,288

23.09

 

 

Application will be made for the New Shares to be admitted to trading on AIM and it is expected that admission will take place on or around 9 March 2021 ("Admission"). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Block Admission Application

Braveheart further announces that an application has been made to the London Stock Exchange for a block admission to trading on AIM of 1,150,000 new ordinary shares of 2p each in the Company ("New Ordinary Shares") (the "Block Admission"). The Block Admission is being made for any issue and allotment of New Ordinary Shares arising from the exercise of options issued pursuant to the award of share options to directors, employees and consultants announced on 17 December 2020, after excluding the above options exercised by Trevor Brown.

Upon issue, the New Ordinary Shares will be issued credited as fully paid and rank pari passu in all respects with the existing ordinary shares of the Company. In accordance with rule 29 of the AIM Rules for Companies, the number of New Ordinary Shares issued and allotted under the Block Admission arrangement will be announced every six months.

It is expected that the Block Admission will become effective on or around 9 March 2021. 

Total Voting Rights

Upon Admission, the issued share capital of the Company will consist of 38,297,451 ordinary shares of 2p each. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company from Admission will be 38,297,451. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

David Worlidge / James Reeve / George Payne

 

 

 

Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Heena Karani / Lucy Williams

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Trevor Brown 

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a) 

Name

Braveheart Investment Group plc

b) 

LEI

2138006HQ3COMU626I61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 2 pence each in Braveheart Investment Group plc

 

 

GB00B13XV322

b)

Nature of the transaction

Exercise of options

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

17p

1,200,000

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount 

N/A

 

e)

Dates of the transaction

3 March 2021

f)

Place of transaction

Outside trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJIMLTMTJMBTB
Date   Source Headline
10th Oct 20251:20 pmRNSConfirmation of change of name and website
26th Sep 20257:00 amRNSProposed Change of Name
9th Sep 20257:00 amRNSBlock admission six monthly return
2nd Sep 202511:23 amRNSHolding(s) in Company
1st Aug 20253:04 pmRNSResult of AGM
9th Jul 20252:41 pmRNSFinal Results and Notice of AGM
30th May 20255:00 pmRNSTotal Voting Rights
27th May 20253:15 pmRNSHolding(s) in Company
21st May 20257:00 amRNSResult of Broker Option and Total Voting Rights
16th May 20252:08 pmRNSPlacing to raise £135,000
14th May 202511:55 amRNSHolding(s) in Company
18th Mar 202510:30 amRNSSubscription in IQ-AI Ltd Placing
6th Mar 202510:03 amRNSBlock admission six monthly return
3rd Feb 20257:00 amRNSCancellation of options
20th Jan 20255:32 pmRNSDirector/PDMR Shareholding - acquisition of shares
14th Jan 202511:15 amRNSHolding(s) in Company
8th Jan 20254:54 pmRNSChange of Auditor
10th Dec 20241:28 pmRNSDirector/PDMR Shareholding
9th Dec 202412:16 pmRNSDirector/PDMR Shareholding - acquisition of shares
2nd Dec 20244:22 pmRNSHolding(s) in Company
2nd Dec 20249:05 amRNSDirector/PDMR Shareholding
7th Nov 202411:10 amRNSHolding(s) in Company
7th Nov 202411:06 amRNSDirector/PDMR Shareholding - acquisition of shares
15th Oct 202410:28 amRNSHolding(s) in Company
15th Oct 20247:00 amRNSHalf-year Report
11th Oct 202410:00 amRNSInvestment in IQ-AI Limited and RPT
26th Sep 20249:35 amRNSAppointment of representative to Board of Autins
9th Sep 202410:15 amRNSBlock admission six monthly return
4th Sep 20247:00 amRNSHolding(s) in Company
20th Aug 20245:15 pmRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSAcquisition of interest in Image Scan Holdings plc
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 20247:00 amRNSInvestment update – Gyrometric
24th Jul 20247:00 amRNSInvestment update - Kirkstall and Paraytec
24th Jul 20247:00 amRNSHolding(s) in Company
18th Jul 20242:23 pmRNSResult of AGM
15th Jul 20244:27 pmRNSGrant of options
26th Jun 20242:03 pmRNSAcquisition of further interest in Autins Group
21st Jun 20247:00 amRNSFinal Results and Notice of AGM
15th May 202411:22 amRNSRevaluation of portfolio assets
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.